ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

FENC Fennec Pharmaceuticals Inc

9.23
0.13 (1.43%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Fennec Pharmaceuticals Inc FENC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.13 1.43% 9.23 07:00:52
개장가 저가 고가 종가 전일 종가
9.23 9.15 9.38 9.23 9.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
21/03/202419:00GLOBEFennec Pharmaceuticals Reports Full Year and Fourth Quarter..
19/03/202419:01GLOBEFennec Pharmaceuticals to Report Full Year and Fourth..
18/03/202416:00PRNUSFennec Pharmaceuticals and Norgine Enter into Exclusive..
18/03/202410:00GLOBEFennec Pharmaceuticals and Norgine Enter into Exclusive..
07/03/202406:07EDGAR2Form 8-K/A - Current report: [Amend]
01/03/202406:04EDGAR2Form 8-K - Current report
29/02/202421:04GLOBEFennec Pharmaceuticals Reports Preliminary Unaudited Net..
15/02/202400:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/02/202419:55GLOBEFDA Issues Reminder of Non-Substitution of PEDMARK® (sodium..
06/01/202407:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:45EDGAR2Form 144 - Report of proposed sale of securities
05/01/202406:42EDGAR2Form 144 - Report of proposed sale of securities
30/12/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202305:51EDGAR2Form 144 - Report of proposed sale of securities
18/12/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
05/12/202319:55GLOBEFennec Announces Incremental $5 Million Investment from..
17/11/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202306:56EDGAR2Form S-3 - Registration statement under Securities Act of..
10/11/202306:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:50GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
10/11/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:19EDGAR2Form 144 - Report of proposed sale of securities
06/11/202319:59GLOBEFennec Pharmaceuticals Announces Third Quarter 2023..
04/11/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202319:45GLOBEFennec Pharmaceuticals to Report Third Quarter 2023..
07/09/202318:59GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
08/08/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/08/202323:51EDGAR2Form 8-K/A - Current report: [Amend]
04/08/202323:58EDGAR2Form 8-K - Current report
04/08/202323:57EDGAR2Form 8-K - Current report
03/08/202318:59GLOBEFennec Pharmaceuticals Announces Second Quarter 2023..
31/07/202318:30GLOBEFennec Pharmaceuticals to Report Second Quarter 2023..
01/07/202305:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/06/202306:00GLOBEFennec Announces Results of Annual Meeting
06/06/202318:44GLOBEFennec Pharmaceuticals Announces European Commission..
11/05/202319:01GLOBEFennec Pharmaceuticals Announces First Quarter 2023..
08/05/202319:15GLOBEFennec Pharmaceuticals to Report First Quarter 2023..

최근 히스토리

Delayed Upgrade Clock